CQDM and the Centre for Probe Development and Commercialization (CPDC) have announced a strategic initiative  to support the development of next-generation radiopharmaceuticals in Canada. This collaboration represents a unique opportunity to align Canada’s strengths and global expertise in this expanding field. Together we are initiating a collective effort that will foster innovation and growth, and we invite all stakeholders to contribute to the advancement and to the future possibilities in Canadian radiopharmaceutical development.

The CQDM and CPDC call for ideas is open to innovative companies and researchers from across Canada. We are searching for world-class research with commercial potential in radiopharmaceuticals to present to the domain experts from CPDC who have created global radiopharmaceutical companies such as Fusion Pharmaceuticals and AtomVie Global Radiopharma. Proposals should focus on enhancing the development of new radiopharmaceuticals, improving medicinal products, and advancing patient outcomes.